Levofloxacin Orion (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. By inhibiting these targets, the drug prevents bacterial DNA synthesis and transcription, leading to bacterial cell death. This mechanism gives levofloxacin a broad spectrum of activity against many Gram‑negative and Gram‑positive organisms.

The dosage of Levofloxacin Orion is determined by the prescribing healthcare professional based on the infection being treated, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for levofloxacin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile before prescribing to pregnant or nursing individuals.

To request Levofloxacin Orion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levofloxacin is the L‑isomer of ofloxacin and generally offers higher potency, better tissue penetration, and a more convenient once‑daily dosing schedule compared with many older fluoroquinolones. Its spectrum covers many respiratory, urinary, and skin pathogens, making it a preferred option when a broad‑spectrum oral agent is needed.

Levofloxacin Orion should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, excessive heat, and direct sunlight to maintain potency throughout the shelf life.

Levofloxacin Orion is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, as these can reduce drug absorption. Swallow the tablet whole; do not crush or chew.

Serious adverse events include tendon rupture (especially in the Achilles tendon), QT‑interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and Clostridioides difficile‑associated diarrhea. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, or severe skin reactions.

Levofloxacin Orion is contraindicated in individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any of the tablet’s excipients. It should also be avoided in patients with a history of tendon disorders related to fluoroquinolone use, those taking concurrent QT‑prolonging drugs without monitoring, and in certain pregnancy or lactation scenarios where risks outweigh benefits.